Francis Laberge

Probability of Cancer in Pulmonary Nodules Detected on First Screening CT

Annette McWilliams, Martin C. Tammemägi, John R. Mayo et al. · New England Journal of Medicine · 2013 · 1.4K citations · Full text

Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

Andrea Bezjak, Dongsheng Tu, Lesley Seymour et al. · Journal of Clinical Oncology · 2006 · 294 citations · Full text

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study

Glenwood Goss, Andrew Arnold, Frances A. Shepherd et al. · Journal of Clinical Oncology · 2009 · 243 citations

Advanced Nsclc, Medicine, Phase Iii +12

Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study

Martin C. Tammemägi, Heidi Schmidt, Simon Martel et al. · The Lancet Oncology · 2017 · 207 citations

Tobacco Control, Preventive Medicine, Cancer Epidemiology +12

Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules

Gerard A. Silvestri, Nichole T. Tanner, Paul Kearney et al. · CHEST Journal · 2018 · 159 citations · Full text